Publications by authors named "Shun Shimizu"

Small-cell lung cancer (SCLC) is an aggressive cancer for which immune checkpoint inhibitors (ICI) have had only limited success. Bispecific T-cell engagers are promising therapeutic alternatives for ICI-resistant tumors, but not all patients with SCLC are responsive. Herein, to integrate CD137 costimulatory function into a T-cell engager format and thereby augment therapeutic efficacy, we generated a CD3/CD137 dual-specific Fab and engineered a DLL3-targeted trispecific antibody (DLL3 trispecific).

View Article and Find Full Text PDF

The extracellular adenosine triphosphate (ATP) concentration is highly elevated in the tumor microenvironment (TME) and remains tightly regulated in normal tissues. Using phage display technology, we establish a method to identify an antibody that can bind to an antigen only in the presence of ATP. Crystallography analysis reveals that ATP bound in between the antibody-antigen interface serves as a switch for antigen binding.

View Article and Find Full Text PDF

One-dimensional self-assembly of macrocycles is one of the important strategies for constructing fibrous nanomaterials with anisotropic functions such as one-dimensional transport and accumulation of molecules and ions. Herein we report on the synthesis and properties of self-assembled nanofibers using macrocycles to develop a multipurpose template for one-dimensional array of noble metal ions. The nanofibers were prepared by protonation-induced self-assembly of bis-phenanthroline macrocycles, which have enabled the accumulation of some metal-containing anions, such as tetrachloroaurate, hexachloroplatinate and phosphomolybdate.

View Article and Find Full Text PDF
Article Synopsis
  • - The study discusses STA551, a novel anti-CD137 switch antibody that activates only in the presence of extracellular adenosine triphosphate (exATP), focusing on its potential to overcome limitations seen in previous CD137 agonists which suffered from toxicity and specificity issues.
  • - STA551 showed strong antitumor effects across various mouse and human tumor models without causing systemic immune activation, indicating a wide therapeutic window and good tolerability even at high doses in monkeys.
  • - The findings suggest STA551 could be a promising treatment option for a broad range of cancers, as it does not rely on specific tumor antigens for efficacy, paving the way for its clinical testing and future developments in cancer therapy.
View Article and Find Full Text PDF

The 5'-untranslated region (5'-UTR) of mRNAs functions as a translation enhancer, promoting translation efficiency. Many in vitro translation systems exhibit a reduced efficiency in protein translation due to decreased translation initiation. The use of a 5'-UTR sequence with high translation efficiency greatly enhances protein production in these systems.

View Article and Find Full Text PDF